Gut microbiome and its role in obesity and insulin resistance
Obesity is a complex metabolic disease caused, in part, by the interaction between an individual's genetics, metabolism, and environment. Emerging evidence supports the role of gut microbiota in mediating the interaction between the host and environment by extracting energy from food otherwise...
Gespeichert in:
| Veröffentlicht in: | Annals of the New York Academy of Sciences 2020-02, Vol.1461 (1), p.37-52 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 52 |
|---|---|
| container_issue | 1 |
| container_start_page | 37 |
| container_title | Annals of the New York Academy of Sciences |
| container_volume | 1461 |
| creator | Lee, Clare J. Sears, Cynthia L. Maruthur, Nisa |
| description | Obesity is a complex metabolic disease caused, in part, by the interaction between an individual's genetics, metabolism, and environment. Emerging evidence supports the role of gut microbiota in mediating the interaction between the host and environment by extracting energy from food otherwise indigestible by the host and producing metabolites and cytokines that affect host metabolism. Furthermore, gut microbial imbalance or dysbiosis has been shown in metabolic diseases including obesity, and recent studies are beginning to unravel the mechanisms involved. The gut microbiota affects host metabolism and obesity through several pathways involving gut barrier integrity, production of metabolites affecting satiety and insulin resistance, epigenetic factors, and metabolism of bile acids and subsequent changes in metabolic signaling. While the field of gut microbiome and its role in obesity is early in its stage of development, it holds a promising future in providing us with novel therapeutic targets that may restore the gut microbiome to a healthy state and help in the prevention and treatment of obesity.
In this review, we provide the latest updates on the gut microbiome and proposed mechanisms through which it contributes to human obesity and insulin resistance. |
| doi_str_mv | 10.1111/nyas.14107 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232003049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2232003049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4237-72c87ea395d54bf9b45c51e3c5bbccfea5bc852f20f621ebba7735e82f7c7373</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK1e_AES8CJC6n5ks8nBQylahaIHe_G07G4msCUfdTdB8u_dmurBg3MZeHl4mXkQuiR4TsLcNYPyc5IQLI7QlIgkj9OU0WM0xViIOMspm6Az77cYE5ol4hRNGMGZYDmZovtV30W1Na7Vtq0hUk0R2c5Hrq0gsk3UavC2G8a88X0VMhci36nGwDk6KVXl4eKwZ2jz-LBZPsXr19XzcrGOTUKZiAU1mQDFcl7wRJe5TrjhBJjhWhtTguLaZJyWFJcpJaC1EoJxyGgpjGCCzdDNWLtz7UcPvpO19QaqSjXQ9l5SyijGDCd5QK__oNu2d004TlLGcY5Tymmgbkcq_O29g1LunK2VGyTBcu9U7p3Kb6cBvjpU9rqG4hf9kRgAMgKftoLhnyr58r54G0u_AI66gKo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2350906252</pqid></control><display><type>article</type><title>Gut microbiome and its role in obesity and insulin resistance</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Lee, Clare J. ; Sears, Cynthia L. ; Maruthur, Nisa</creator><creatorcontrib>Lee, Clare J. ; Sears, Cynthia L. ; Maruthur, Nisa</creatorcontrib><description>Obesity is a complex metabolic disease caused, in part, by the interaction between an individual's genetics, metabolism, and environment. Emerging evidence supports the role of gut microbiota in mediating the interaction between the host and environment by extracting energy from food otherwise indigestible by the host and producing metabolites and cytokines that affect host metabolism. Furthermore, gut microbial imbalance or dysbiosis has been shown in metabolic diseases including obesity, and recent studies are beginning to unravel the mechanisms involved. The gut microbiota affects host metabolism and obesity through several pathways involving gut barrier integrity, production of metabolites affecting satiety and insulin resistance, epigenetic factors, and metabolism of bile acids and subsequent changes in metabolic signaling. While the field of gut microbiome and its role in obesity is early in its stage of development, it holds a promising future in providing us with novel therapeutic targets that may restore the gut microbiome to a healthy state and help in the prevention and treatment of obesity.
In this review, we provide the latest updates on the gut microbiome and proposed mechanisms through which it contributes to human obesity and insulin resistance.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/nyas.14107</identifier><identifier>PMID: 31087391</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Bariatric Surgery ; Bile acids ; Cytokines ; Developmental stages ; Digestive system ; Dysbacteriosis ; Energy Metabolism ; Gastrointestinal Microbiome ; Genetics ; gut microbiome ; Humans ; Insulin ; Insulin Resistance ; Intestinal microflora ; Metabolic disorders ; Metabolism ; Metabolites ; Microbiomes ; Microbiota ; Microorganisms ; Obesity ; Obesity - microbiology ; Resistance factors ; Satiety ; Therapeutic applications</subject><ispartof>Annals of the New York Academy of Sciences, 2020-02, Vol.1461 (1), p.37-52</ispartof><rights>2019 New York Academy of Sciences.</rights><rights>2020 The New York Academy of Sciences</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4237-72c87ea395d54bf9b45c51e3c5bbccfea5bc852f20f621ebba7735e82f7c7373</citedby><cites>FETCH-LOGICAL-c4237-72c87ea395d54bf9b45c51e3c5bbccfea5bc852f20f621ebba7735e82f7c7373</cites><orcidid>0000-0002-0824-0207</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fnyas.14107$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fnyas.14107$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31087391$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Clare J.</creatorcontrib><creatorcontrib>Sears, Cynthia L.</creatorcontrib><creatorcontrib>Maruthur, Nisa</creatorcontrib><title>Gut microbiome and its role in obesity and insulin resistance</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Obesity is a complex metabolic disease caused, in part, by the interaction between an individual's genetics, metabolism, and environment. Emerging evidence supports the role of gut microbiota in mediating the interaction between the host and environment by extracting energy from food otherwise indigestible by the host and producing metabolites and cytokines that affect host metabolism. Furthermore, gut microbial imbalance or dysbiosis has been shown in metabolic diseases including obesity, and recent studies are beginning to unravel the mechanisms involved. The gut microbiota affects host metabolism and obesity through several pathways involving gut barrier integrity, production of metabolites affecting satiety and insulin resistance, epigenetic factors, and metabolism of bile acids and subsequent changes in metabolic signaling. While the field of gut microbiome and its role in obesity is early in its stage of development, it holds a promising future in providing us with novel therapeutic targets that may restore the gut microbiome to a healthy state and help in the prevention and treatment of obesity.
In this review, we provide the latest updates on the gut microbiome and proposed mechanisms through which it contributes to human obesity and insulin resistance.</description><subject>Animals</subject><subject>Bariatric Surgery</subject><subject>Bile acids</subject><subject>Cytokines</subject><subject>Developmental stages</subject><subject>Digestive system</subject><subject>Dysbacteriosis</subject><subject>Energy Metabolism</subject><subject>Gastrointestinal Microbiome</subject><subject>Genetics</subject><subject>gut microbiome</subject><subject>Humans</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Intestinal microflora</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Microbiomes</subject><subject>Microbiota</subject><subject>Microorganisms</subject><subject>Obesity</subject><subject>Obesity - microbiology</subject><subject>Resistance factors</subject><subject>Satiety</subject><subject>Therapeutic applications</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRbK1e_AES8CJC6n5ks8nBQylahaIHe_G07G4msCUfdTdB8u_dmurBg3MZeHl4mXkQuiR4TsLcNYPyc5IQLI7QlIgkj9OU0WM0xViIOMspm6Az77cYE5ol4hRNGMGZYDmZovtV30W1Na7Vtq0hUk0R2c5Hrq0gsk3UavC2G8a88X0VMhci36nGwDk6KVXl4eKwZ2jz-LBZPsXr19XzcrGOTUKZiAU1mQDFcl7wRJe5TrjhBJjhWhtTguLaZJyWFJcpJaC1EoJxyGgpjGCCzdDNWLtz7UcPvpO19QaqSjXQ9l5SyijGDCd5QK__oNu2d004TlLGcY5Tymmgbkcq_O29g1LunK2VGyTBcu9U7p3Kb6cBvjpU9rqG4hf9kRgAMgKftoLhnyr58r54G0u_AI66gKo</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Lee, Clare J.</creator><creator>Sears, Cynthia L.</creator><creator>Maruthur, Nisa</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0824-0207</orcidid></search><sort><creationdate>202002</creationdate><title>Gut microbiome and its role in obesity and insulin resistance</title><author>Lee, Clare J. ; Sears, Cynthia L. ; Maruthur, Nisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4237-72c87ea395d54bf9b45c51e3c5bbccfea5bc852f20f621ebba7735e82f7c7373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Bariatric Surgery</topic><topic>Bile acids</topic><topic>Cytokines</topic><topic>Developmental stages</topic><topic>Digestive system</topic><topic>Dysbacteriosis</topic><topic>Energy Metabolism</topic><topic>Gastrointestinal Microbiome</topic><topic>Genetics</topic><topic>gut microbiome</topic><topic>Humans</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Intestinal microflora</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Microbiomes</topic><topic>Microbiota</topic><topic>Microorganisms</topic><topic>Obesity</topic><topic>Obesity - microbiology</topic><topic>Resistance factors</topic><topic>Satiety</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Clare J.</creatorcontrib><creatorcontrib>Sears, Cynthia L.</creatorcontrib><creatorcontrib>Maruthur, Nisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Clare J.</au><au>Sears, Cynthia L.</au><au>Maruthur, Nisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gut microbiome and its role in obesity and insulin resistance</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2020-02</date><risdate>2020</risdate><volume>1461</volume><issue>1</issue><spage>37</spage><epage>52</epage><pages>37-52</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Obesity is a complex metabolic disease caused, in part, by the interaction between an individual's genetics, metabolism, and environment. Emerging evidence supports the role of gut microbiota in mediating the interaction between the host and environment by extracting energy from food otherwise indigestible by the host and producing metabolites and cytokines that affect host metabolism. Furthermore, gut microbial imbalance or dysbiosis has been shown in metabolic diseases including obesity, and recent studies are beginning to unravel the mechanisms involved. The gut microbiota affects host metabolism and obesity through several pathways involving gut barrier integrity, production of metabolites affecting satiety and insulin resistance, epigenetic factors, and metabolism of bile acids and subsequent changes in metabolic signaling. While the field of gut microbiome and its role in obesity is early in its stage of development, it holds a promising future in providing us with novel therapeutic targets that may restore the gut microbiome to a healthy state and help in the prevention and treatment of obesity.
In this review, we provide the latest updates on the gut microbiome and proposed mechanisms through which it contributes to human obesity and insulin resistance.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31087391</pmid><doi>10.1111/nyas.14107</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-0824-0207</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0077-8923 |
| ispartof | Annals of the New York Academy of Sciences, 2020-02, Vol.1461 (1), p.37-52 |
| issn | 0077-8923 1749-6632 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2232003049 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Animals Bariatric Surgery Bile acids Cytokines Developmental stages Digestive system Dysbacteriosis Energy Metabolism Gastrointestinal Microbiome Genetics gut microbiome Humans Insulin Insulin Resistance Intestinal microflora Metabolic disorders Metabolism Metabolites Microbiomes Microbiota Microorganisms Obesity Obesity - microbiology Resistance factors Satiety Therapeutic applications |
| title | Gut microbiome and its role in obesity and insulin resistance |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A58%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gut%20microbiome%20and%20its%20role%20in%20obesity%20and%20insulin%20resistance&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Lee,%20Clare%20J.&rft.date=2020-02&rft.volume=1461&rft.issue=1&rft.spage=37&rft.epage=52&rft.pages=37-52&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/nyas.14107&rft_dat=%3Cproquest_cross%3E2232003049%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2350906252&rft_id=info:pmid/31087391&rfr_iscdi=true |